Publish Your Medical Research Articles and Get Rewarded for Your Knowledge
Register to submit your paper, and Start Earning from your Research Articles
In the fast-moving world of academic research, getting your work published can be one of the most rewarding — and challenging — parts of your career. Whether you’ve written a detailed medical study, a health policy review, or a deep-dive into clinical decision-making, your research deserves to be seen, read, and shared. Our platform invites researchers to submit their medical articles to a professional environment that values scholarly articles without the delays or restrictions of traditional peer reviewed articles.
An Alternative to Peer Reviewed Journal Articles
While many researchers are drawn to peer reviewed journal articles or scholarly journal articles for credibility, these processes can often take months or even years before your findings reach readers. Our publishing model offers a flexible alternative: fast, non-peer reviewed publication with the additional benefit of article monetisation. We believe your research shouldn’t just earn you recognition — it should reward you financially as well.
Your Work Deserves Visibility
Whether your work fits the category of peer reviewed research articles or would typically appear in a medical journal, our platform offers visibility across a wide audience of scholars, health professionals, and students. Unlike conventional peer reviewed articles databases, which often gate content behind expensive subscriptions, our system ensures your work remains accessible — meaning your discoveries can travel farther and faster.
Open Access Meets Monetisation
Many academic journal articles never reach their full audience because of outdated paywalls or restrictive copyright policies. On our platform, however, researchers keep their rights and benefit directly from the engagement their research generates. We welcome both seasoned professionals and new contributors, offering a home for everything from scientific articles to detailed scholarly sources.
Faster Publication for Growing Impact
Publishing on our platform also increases the chance of your work being referenced in future journal articles, cited in scientific papers, or used as teaching material in academic journals and medical classrooms worldwide. We aim to make research articles easy to find, easy to read, and easy to share.
Your Research, Your Rewards
Our model is also designed for those exploring alternative routes to traditional publishing. If you’ve struggled with submission guidelines, peer review waitlists, or pay-to-publish journal policies, you’ll find our system refreshingly simple. Researchers can submit their work, gain exposure through academic databases, and start earning from article downloads and reads — all without facing the bottlenecks common in scholarly journal databases.
The Future of Medical Publishing
The future of research is open, fast, and collaborative. Whether your work is clinical, theoretical, or practice-based, our platform offers the perfect space to turn your research into real-world impact.
Medicine Articles
Objective
To establish a simple electrophysiological scale for patients with distal symmetric axonal polyneuropathy, in order to promote standardized and informative electrodiagnostic reporting, and understand the complex relationship between electrophysiological and clinical polyneuropathy severity.
Methods
We included 76 patients with distal symmetric axonal polyneuropathy, from a cohort ...
7 months ago
Abstract
Background
An intervention to reduce low-value magnetic resonance imaging (MRI) was designed and implemented in private imaging centres in Norway in October 2022. The intervention used return letters for poor referrals of MRI of the lower back, brain and knee at private imaging centres in Norway. The study aimed to investigate key stakeholders’ experien...
7 months ago
The coronavirus disease 2019 (COVID-19) pandemic has affected vulnerable households’ livelihoods in developing countries. Using high-frequency phone survey data from the World Bank, we assess rural Indian households’ vulnerability and poverty status during the pandemic. Results reveal that over three-fifths of Indian rural households are vulnerable to poverty in the context of COVID-19, despit...
7 months ago
Melissa J. L. Bonorden,
Melissa J. L. Bonorden
The Hormel Institute, University of Minnesota, Austin, MN 55912, USA
Michael E. Grossmann,
Michael E. Grossmann
The Hormel Institute, University of Minnesota, Austin, MN 55912, USA
Sarah A. Ewing,
Sarah A. Ewing
The Hormel Institute, University of Minnesota, Austin, MN 55912, USA
Olga P. Rogozina,
Olga P. Rogozina
The Hormel Institute, University of Minnesota, Austin, MN 55912, USA
Amitabha Ray,
Amitabha Ray
The Hormel Institute, University of Minnesota, Austin, MN 55912, USA
Katai J. Nkhata,
Katai J. Nkhata
The Hormel Institute, University of Minnesota, Austin, MN 55912, USA
D. Joshua Liao,
D. Joshua Liao
The Hormel Institute, University of Minnesota, Austin, MN 55912, USA
Joseph P. Grande,
Joseph P. Grande
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
Margot P. Cleary
Margot P. Cleary
The Hormel Institute, University of Minnesota, Austin, MN 55912, USA
To clarify effects of diet and body weight on prostate cancer development, three studies were undertaken using the TRAMP mouse model of this disease. In the first experiment, obesity was induced by injection of gold thioglucose (GTG). Age of prostate tumor detection (~33 wk) and death (~43 wk) was not significantly different among the groups. In the second study, TRAMP-C2 cells were injected i...
7 months ago
Hereditary non-polyposis colorectal cancer (HNPCC) is an inherited disorder characterized by an increased risk of developing colorectal cancer before age 50. HNPCC is predominantly caused by genetic mutations in MLH1 and MSH2, which are involved in DNA mismatch repair. Current standard practice is to perform prophylactic colectomy, resulting in debilitating aftereffects for life. Though the geneti...
8 months ago
Maneesh Singh
Maneesh Singh
Kansas City university
Introduction.
Hereditary non-polyposis colorectal cancer is also known as Lynch syndrome. It is autosomal dominant and
is one of the most common causes of inherited colon cancer. A family history of colorectal cancer in
first-degree relatives in two generations, and one case before the age of 50 is seen with Lynch syndrome
The purpose of this paper is to provide a review of hereditary non-p...
8 months ago
Pierre-Alexandre Just,
Pierre-Alexandre Just
NULL
Background
Hereditary papillary renal cell carcinoma (HPRCC) is a rare autosomal dominant disease characterized by the development of multiple and bilateral papillary type I renal cell carcinomas (RCC) and papillary adenomas caused by activating mutations in the MET proto-oncogene. Classically, distinctive histological features of RCC are described according to the familial renal cell carcinoma s...
8 months ago
In hereditary leiomyomatosis and renal cell carcinoma syndrome, fumarate hydratase–deficient renal cell carcinomas typically present as aggressive, unilateral, often cystic masses with heterogeneous enhancement. These tumors can metastasize early, making appropriate imaging and staging critical for diagnosis and management.
Teaching point: When a renal lesion suspected of RCC is identified in...
8 months ago
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome is believed to result from an autosomal dominant mutation in the fumarate hydratase (FH) gene on chromosome 1. It is characterized by leiomyomas, mainly uterine or cutaneous, and renal cell carcinoma (RCC). The most common type of RCC associated with HLRCC is type II papillary RCC although other types are seen. Of note, chromophob...
8 months ago
Jianliang Liu,
Jianliang Liu
E.J. Whitten Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, VIC 3005, Australia
Thomas P. Cundy,
Thomas P. Cundy
Discipline of Surgery, University of Adelaide, Adelaide, SA 5005, Australia
Dixon T. S. Woon,
Dixon T. S. Woon
E.J. Whitten Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, VIC 3005, Australia
Nathan Lawrentschuk
Nathan Lawrentschuk
E.J. Whitten Prostate Cancer Research Centre, Epworth Healthcare, Melbourne, VIC 3005, Australia
Early detection of metastatic prostate cancer (mPCa) is crucial. Whilst the prostate-specific membrane antigen (PSMA) PET scan has high diagnostic accuracy, it suffers from inter-reader variability, and the time-consuming reporting process. This systematic review was registered on PROSPERO (ID CRD42023456044) and aims to evaluate AI’s ability to enhance reporting, diagnostics, and predic...
8 months ago